Phase III Study in First-line Treatment of Patients With Metastatic Colorectal Cancer Who Are Not Candidate for Intensive Therapy.
ACTIVE_NOT_RECRUITING
Status
Conditions
- Metastatic Colorectal Cancer
Interventions
- DRUG: Trifluridine/tipiracil hydrochloride (S95005)
- DRUG: Capecitabine
- BIOLOGICAL: Bevacizumab experimental
- BIOLOGICAL: Bevacizumab control
Sponsor
Institut de Recherches Internationales Servier
Collaborators